Evidence map›Paper›PMID 24613321›Full record

ArticleJournal of the American College of Cardiology2014

Release and capture of bioactive oxidized phospholipids and oxidized cholesteryl esters during percutaneous coronary and peripheral arterial interventions in humans.

Amir Ravandi, Gregor Leibundgut, Ming-Yow Hung, Mitul Patel, Patrick M Hutchins, Robert C Murphy, Anand Prasad, Ehtisham Mahmud, Yury I Miller, Edward A Dennis and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American College of Cardiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Oxidized Phospholipids and Calcific Aortic Valvular Disease.Journal of the American College of Cardiology · 2024
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Oxidized phospholipids in cardiovascular disease.Nature reviews. Cardiology · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Amir RavandiSt. Boniface Hospital Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Medicine, University of California-San Diego, La Jolla, California.
Gregor LeibundgutDepartment of Medicine, University of California-San Diego, La Jolla, California; University of Basel, Basel, Switzerland.
Ming-Yow HungDepartment of Medicine, University of California-San Diego, La Jolla, California; Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
Mitul PatelDepartment of Medicine, University of California-San Diego, La Jolla, California.
Patrick M HutchinsDepartment of Pharmacology, University of Colorado Denver, Aurora, Colorado.
Robert C MurphyDepartment of Pharmacology, University of Colorado Denver, Aurora, Colorado.
Anand PrasadDepartment of Medicine, University of California-San Diego, La Jolla, California; Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Ehtisham MahmudDepartment of Medicine, University of California-San Diego, La Jolla, California.
Yury I MillerDepartment of Medicine, University of California-San Diego, La Jolla, California.
Edward A DennisDepartment of Pharmacology and Chemistry and Biochemistry, University of California, La Jolla, California.
Joseph L WitztumDepartment of Medicine, University of California-San Diego, La Jolla, California.
Sotirios TsimikasDepartment of Medicine, University of California-San Diego, La Jolla, California. Electronic address: stsimikas@ucsd.edu.
University of California San Diego · USUniversity of Colorado Denver · USSt. Boniface Hospital · CATaipei Medical University Hospital · TWThe University of Texas Health Science Center at San Antonio · USUniversity of Basel · CH

Funding

STEROL LIPIDSU54GM069338 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DENNIS, EDWARD A · 2003 to 2013
$72.2M
ROLE OF LIPOXYGENASES IN ATHEROGENESIS IN DIABETES MELLITUSP01HL055798 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI TAYLOR, ANGELA M · 1995 to 2016
$28.4M
Transcriptional GenomicsP01HL088093 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WITZTUM, JOSEPH L. · 2008 to 2018
$26.4M
Zebrafish models of vascular inflammation and atherosclerosisR01HL093767 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MILLER, YURY · 2009 to 2014
$2.5M
NHLBI NIH HHS P01 HL055798NHLBI NIH HHS P01 HL088093NHLBI NIH HHS R01 HL093767NIGMS NIH HHS U54 GM069338
6 · The paper itself

Abstract

objectivesThis study sought to assess whether oxidized lipids are released downstream from obstructive plaques after percutaneous coronary and peripheral interventions using distal protection devices.

backgroundOxidation of lipoproteins generates multiple bioactive oxidized lipids that affect atherothrombosis and endothelial function. Direct evidence of their role during therapeutic procedures, which may result in no-reflow phenomenon, myocardial infarction, and stroke, is lacking.

methodsThe presence of specific oxidized lipids was assessed in embolized material captured by distal protection filter devices during uncomplicated saphenous vein graft, carotid, renal, and superficial femoral artery interventions. The presence of oxidized phospholipids (OxPL) and oxidized cholesteryl esters (OxCE) was evaluated in 24 filters using liquid chromatography, tandem mass spectrometry, enzyme-linked immunosorbent assays, and immunostaining.

resultsPhosphatidylcholine-containing OxPL, including (1-palmitoyl-2-[9-oxo-nonanoyl] PC), representing a major phosphatidylcholine-OxPL molecule quantitated within plaque material, [1-palmitoyl-2-(5-oxo-valeroyl)-sn-glycero-3-phosphocholine], and 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphocholine, were identified in the extracted lipid portion from all vascular beds. Several species of OxCE, such as keto, hydroperoxide, hydroxy, and epoxy cholesteryl ester derivatives from cholesteryl linoleate and cholesteryl arachidonate, were also present. The presence of OxPL was confirmed using enzyme-linked immunoassays and immunohistochemistry of captured material.

conclusionsThis study documents the direct release and capture of OxPL and OxCE during percutaneous interventions from multiple arterial beds in humans. Entrance of bioactive oxidized lipids into the microcirculation may mediate adverse clinical outcomes during therapeutic procedures.

Indexed as

AgedAged, 80 and overCatheterization, PeripheralCholesterol EstersChromatography, High Pressure LiquidEnzyme-Linked Immunosorbent AssayFemaleHumansMaleMiddle AgedOxidation-ReductionPercutaneous Coronary InterventionPeripheral Arterial DiseasePhosphatidylcholinesPhospholipidsTandem Mass SpectrometryCholesterol EstersPhosphatidylcholinesPhospholipidsangioplastylipoproteinsoxidized cholesteryl estersoxidized phospholipids

Identifiers

PMID24613321
PMCPMC4629781
OpenAlexW2050228630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.